Genome Medicine
The Campus
4 Crinan Street
London N1 9XW
United Kingdom
If you wish to make a presubmission enquiry about the suitability of your manuscript, or if you have any other editorial enquiry, please email the editors who will respond to you as soon as possible.
Announcements
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
COVID-19 submissions
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.
2022 Citation Impact
12.3 - 2-year Impact Factor
13.8 - 5-year Impact Factor
2.422 - SNIP (Source Normalized Impact per Paper)
4.851 - SJR (SCImago Journal Rank)
2022 Speed
64 days submission to first editorial decision for all manuscripts (Median)
212 days submission to accept (Median)
2022 Usage
1,991,217 downloads
14,220 Altmetric mentions
